On February 21, 2024, the Board of Directors of CNS Pharmaceuticals, Inc. approved the following appointments to its Board committees: (i) Audit Committee Jeff Keyes (Chair), Carl Evans and Amy Mahery; (ii) Compensation Committee Dr. Jerzy (George) Gumulka (Chair), Jeff Keyes and Dr. Bettina Cockroft; and (iii) Nominating and Governance Committee Dr. Bettina Cockroft (Chair) and Faith Charles.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.215 USD | +5.39% | +6.44% | -83.07% |
Apr. 23 | Transcript : CNS Pharmaceuticals, Inc. - Special Call | |
Apr. 01 | CNS Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-83.07% | 2.29M | |
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CNSP Stock
- News CNS Pharmaceuticals, Inc.
- CNS Pharmaceuticals, Inc. Approves the Appointments to its Board Committees